Renal Cancer - Results from #1420

Reliable Prediction of Post-Operative Complications' Rate Using the G8 Screening Tool: A Prospective Study on Elderly Patients Undergoing Surgery for Kidney Cancer. July 12, 2022

Association of Energy Expenditure and Efficacy in Metastatic Renal Cell Carcinoma Patients Treated with Nivolumab. July 12, 2022

Systematic Construction and Validation of a Novel Macrophage Differentiation-Associated Prognostic Model for Clear Cell Renal Cell Carcinoma. July 11, 2022

Outcomes of nephrectomy for renal cell carcinoma: An ecologic retrospective study in a middle-income country. July 11, 2022

Evolving landscape of first-line combination therapy in advanced renal cancer: a systematic review. July 8, 2022

Statin use improves the efficacy of nivolumab in patients with advanced renal cell carcinoma. July 8, 2022

Prognostic value of the ratio of maximum to minimum diameter of primary tumor in metastatic clear cell renal cell carcinoma. July 7, 2022

Comprehensive Evaluation of the m6A Regulator Prognostic Risk Score in the Prediction of Immunotherapy Response in Clear Cell Renal Cell Carcinoma. July 7, 2022

A Decade of Robotic-Assisted Radical Nephrectomy with Inferior Vena Cava Thrombectomy: A Systematic Review and Meta-Analysis of Perioperative Outcomes. July 6, 2022

Advanced nccRCC: what therapeutic options in 2022? July 6, 2022

Diagnostic accuracy of 99mTc-Sestamibi SPECT/CT for characterization of solid renal masses. July 5, 2022

ARL4C Regulates the Progression of Clear Cell Renal Cell Carcinoma by Affecting the Wnt/β-Catenin Signaling Pathway. July 5, 2022

Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma. July 4, 2022

The Role of Cytoreductive Nephrectomy and Targeted Therapy on Outcomes of Patients With Metastatic Sarcomatoid Renal Cell Carcinoma: A Population-Based Analysis. July 4, 2022

An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinoma. July 1, 2022

A clinical investigation of recurrence and lost follow-up after renal cell carcinoma surgery: a single-center, long-term, large cohort, retrospective study. July 1, 2022

Real World Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Only Available Sunitinib and Pazopanib in First-Line Setting. June 30, 2022

Systemic Immunological Determinants of Oncological Outcomes After Surgery for Localized Renal Cell Carcinoma. June 30, 2022

Therapeutic sequencing in the era of first-line immune checkpoint inhibitor combinations, a novel challenge in patients with metastatic clear-cell renal cell carcinoma. June 29, 2022

A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear Cell Renal Cell Carcinoma. June 29, 2022

Page 72 of 456